Flu vaccine efficacy problems prompt switch in U.K. to Seqirus' Fluad for over-75s

Flu vaccine efficacy problems prompt switch in U.K. to Seqirus' Fluad for over-75s

Seqirus' Fluad is set for U.K. use in people 75 and older next flu season.

Decades after approvals elsewhere, Seqirus' adjuvanted flu vaccine Fluad is finally set for routine use in the U.K. because the current shot isn't working for the elderly.